Y-mAbs Therapeutics, Inc.: net_income
| Value | {"amount": -81028000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | Y-mAbs Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:37:23.958445+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0be8faf1-c3ad-4ecb-ab1c-52f49e7ad6f1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-002551Retrieved: 2026-08-19T17:37:23.958445+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001722964/net-income/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0be8faf1-c3ad-4ecb-ab1c-52f49e7ad6f1
History
- no predecessors — first report